Extended and beyond total mesorectal excisions (TME) for advanced and recurrent rectal
cancers are increasingly performed with acceptable oncological and functional outcomes …

Aim Pelvic exenteration surgery can improve survival in people with advanced colorectal
cancer. This systematic review aimed to review pain intensity and other outcomes, for …

Background Pelvic exenteration is a procedure with high morbidity despite careful patient
selection. This study investigates potential associations between perioperative markers and …

Objective To establish the feasibility and acceptability of a preoperative exercise program,
and to obtain pilot data on the likely difference in key surgical outcomes to inform the sample …

Background To determine surgical, survival and quality of life outcomes across different
tumour streams and lessons learned over 28 years. Methods Consecutive patients …

Aim Pelvic exenteration (PE) has become the standard of care for locally advanced and
recurrent rectal cancer. The high short‐term morbidity reported from this procedure is well …

After more than 25 years of performing pelvic exenteration for advanced primary and
recurrent pelvic malignancy (Table 1) it is cathartic not only to explore how the concepts of …

Aim Pelvic exenteration (PE) carries high morbidity. Our aim was to analyse the use of
patient‐reported outcome measures (PROMs) in PE patients. Method Search strategies …

This review outlines the role of pelvic exenteration (PE) in the management of certain locally-
advanced primary and recurrent rectal cancers. PE has undergone significant evolution over …

Background. Pelvic exenteration (PE) is a complex operative procedure, reserved for
patients with locally advanced and recurrent pelvic malignancies. PE is associated with a …